133
Participants
Start Date
April 30, 2014
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
Clinical Assessment
HL treatment will be determined by review of available medical records as archived at MSKCC. Recorded variables will include: (1) RT - field, fractional and cumulative dose, and duration; (2) chemotherapy - regimen, planned interval, dose per cycle, and cumulative dosages. Patients will also be asked to complete the FACT-LYM questionnaire and the FACIT Fatigue questionnaire.
Stress cardiac MRI
Both imaging tests will be performed within a 30 day interval, with the two modalities interpreted by dedicated study investigators blinded to the results of the other modality.
Stress echocardiogram
Both imaging tests will be performed within a 30 day interval, with the two modalities interpreted by dedicated study investigators blinded to the results of the other modality.
Memorial Sloan Kettering Cancer Center, New York
Weill Medical College of Cornell University
OTHER
Memorial Sloan Kettering Cancer Center
OTHER